Commonwealth Equity Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.32M Sell
17,755
-664
-4% -$349K 0.01% 957
2025
Q1
$11.7M Buy
18,419
+405
+2% +$257K 0.02% 780
2024
Q4
$12.8M Sell
18,014
-967
-5% -$689K 0.02% 705
2024
Q3
$20M Sell
18,981
-1,171
-6% -$1.23M 0.03% 519
2024
Q2
$21.2M Buy
20,152
+780
+4% +$820K 0.03% 480
2024
Q1
$18.6M Buy
19,372
+526
+3% +$506K 0.03% 516
2023
Q4
$16.6M Buy
18,846
+508
+3% +$446K 0.03% 521
2023
Q3
$15.1M Sell
18,338
-64
-0.3% -$52.7K 0.03% 516
2023
Q2
$13.2M Sell
18,402
-2,254
-11% -$1.62M 0.03% 571
2023
Q1
$17K Buy
20,656
+183
+0.9% +$150 0.04% 451
2022
Q4
$14.8M Buy
20,473
+3,600
+21% +$2.6M 0.04% 480
2022
Q3
$11.6M Sell
16,873
-820
-5% -$565K 0.03% 518
2022
Q2
$10.5M Buy
17,693
+1,551
+10% +$917K 0.03% 564
2022
Q1
$11.3M Sell
16,142
-6,025
-27% -$4.21M 0.03% 574
2021
Q4
$14M Sell
22,167
-1,867
-8% -$1.18M 0.03% 480
2021
Q3
$14.5M Buy
24,034
+7,628
+46% +$4.62M 0.04% 435
2021
Q2
$9.16M Buy
16,406
+2,200
+15% +$1.23M 0.02% 591
2021
Q1
$6.72M Buy
14,206
+2,390
+20% +$1.13M 0.02% 652
2020
Q4
$5.71M Sell
11,816
-392
-3% -$189K 0.02% 667
2020
Q3
$6.83M Sell
12,208
-596
-5% -$334K 0.02% 552
2020
Q2
$7.99M Buy
12,804
+1,921
+18% +$1.2M 0.03% 478
2020
Q1
$5.31M Buy
10,883
+1,413
+15% +$690K 0.02% 530
2019
Q4
$3.56M Sell
9,470
-527
-5% -$198K 0.01% 748
2019
Q3
$2.77M Buy
9,997
+416
+4% +$115K 0.01% 808
2019
Q2
$3M Buy
9,581
+726
+8% +$227K 0.01% 763
2019
Q1
$3.64M Sell
8,855
-80
-0.9% -$32.8K 0.02% 666
2018
Q4
$3.34M Buy
8,935
+997
+13% +$372K 0.02% 635
2018
Q3
$3.21M Buy
7,938
+1,481
+23% +$598K 0.02% 691
2018
Q2
$2.23M Buy
6,457
+771
+14% +$266K 0.01% 849
2018
Q1
$1.96M Buy
5,686
+427
+8% +$147K 0.01% 876
2017
Q4
$1.98M Buy
5,259
+158
+3% +$59.4K 0.01% 860
2017
Q3
$2.28M Buy
5,101
+162
+3% +$72.4K 0.01% 743
2017
Q2
$2.43M Sell
4,939
-717
-13% -$352K 0.02% 684
2017
Q1
$2.19M Buy
5,656
+633
+13% +$245K 0.01% 699
2016
Q4
$1.84M Sell
5,023
-42
-0.8% -$15.4K 0.01% 737
2016
Q3
$2.04M Buy
5,065
+59
+1% +$23.7K 0.02% 675
2016
Q2
$1.75M Buy
5,006
+695
+16% +$243K 0.01% 710
2016
Q1
$1.55M Buy
4,311
+2
+0% +$721 0.01% 746
2015
Q4
$2.34M Buy
4,309
+39
+0.9% +$21.2K 0.02% 565
2015
Q3
$1.99M Sell
4,270
-8
-0.2% -$3.72K 0.02% 601
2015
Q2
$2.18M Sell
4,278
-529
-11% -$270K 0.02% 592
2015
Q1
$2.17M Sell
4,807
-734
-13% -$331K 0.02% 572
2014
Q4
$2.27M Buy
5,541
+1,422
+35% +$583K 0.03% 526
2014
Q3
$1.49M Buy
4,119
+125
+3% +$45.1K 0.02% 666
2014
Q2
$1.13M Sell
3,994
-961
-19% -$271K 0.01% 806
2014
Q1
$1.49M Buy
4,955
+763
+18% +$229K 0.02% 626
2013
Q4
$1.15M Buy
4,192
+213
+5% +$58.6K 0.02% 697
2013
Q3
$1.25M Buy
3,979
+847
+27% +$265K 0.02% 622
2013
Q2
$704K Buy
+3,132
New +$704K 0.01% 855